Published in Gene Therapy Weekly, March 11th, 1996
The resulting vaccines have the potential for both prophylactic and therapeutic applications.
The method is called expression library cloning. This involves systematically breaking down the genome of a pathogen into segments that can be manipulated until the most immunogenic epitopes are found.
"The problem with DNA vaccines is that, unlike live vaccines, the [immunogenic ] antigen must be defined," said researcher Stephen A. Johnston of the University of Texas Southwestern Medical Center,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (1996-03-11)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.